Q: Can you help estimate the market value of MedReleaf?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Any comments on MedReleaf (TSX symbol LEAF)
$100mm IPO Priced at $9.50 on Jun 7th, 2017.
I guess my question is, If you were fan of Cannabis, would you invest in LEAF!
$100mm IPO Priced at $9.50 on Jun 7th, 2017.
I guess my question is, If you were fan of Cannabis, would you invest in LEAF!
Q: Hi,
I have always considered tech companies like OTEX, KXS, medical companies like GUD, CCL.b and food companies like ATD.b, MRU to be non cyclical or at least below-average, is this correct?
Could you please give a list of companies from BEST to OKAY.
HD
I have always considered tech companies like OTEX, KXS, medical companies like GUD, CCL.b and food companies like ATD.b, MRU to be non cyclical or at least below-average, is this correct?
Could you please give a list of companies from BEST to OKAY.
HD
Q: Is there a publicly traded company focused on animal health such as pharmaceutical or general medical services. I think the pet industry is hugh but not sure where to invest.
Q: Any thoughts on this micro-cap name? Streaming concept seems interesting, given new recreational marijuana industry being created.
Q: Hi Team,
Kindly provide any insights into the $2.5B US Shelf Prospectus filed by Shopify today. Many thanks. Michael
Kindly provide any insights into the $2.5B US Shelf Prospectus filed by Shopify today. Many thanks. Michael
Q: Sell or Hold ? Thank you
Q: What do you make of the most recent earnings announcement and why is the liquidity so thin? I would have thought that after several years of growth and profitability the institutional market would have been interested in picking up some ownership from the tightly owned group. My other question is why would Bennett who appears to own over 63% of the company list it if he is not willing to distribute stock to others, isn't that a very costly venture to list a company public for no other reason that to see its name listed (sarcasm here!)
Q: Please tell me what you think of Sierra's results this quarter. In the past you have not liked Sierra's prospects. It was recently recommended on BNN.
Thanks Jean
Thanks Jean
Q: With global expansion ripening, can I get your thoughts on a GOOS position in a growth portfolio.
thanks
thanks
Q: Would appreciate your views on the latest results from Napec. Nice to see them swing back to a profit and they also had a significant increase in their backlog. The market seems to agree and the stock is being rewarded.
Keep up the great work.
Keep up the great work.
Q: Hey Peter and Co.:
I own the following stocks:
BNS, CCL.B, CNR, CGX, CSU, KXS, GUD, MG, MX, NFI, PPL, PBH, SIS, TOY, SJ, T, WSP, ZCL, VET, BCE, ENGH, TD.
I'm looking for a growth stock to add to my TFSA. I bought SIS for my TFSA last year and it's gone up nearly 100%, so thank you for that! What would you recommend here?
Thanks for all of your great advice over the years. cheers
Andy
I own the following stocks:
BNS, CCL.B, CNR, CGX, CSU, KXS, GUD, MG, MX, NFI, PPL, PBH, SIS, TOY, SJ, T, WSP, ZCL, VET, BCE, ENGH, TD.
I'm looking for a growth stock to add to my TFSA. I bought SIS for my TFSA last year and it's gone up nearly 100%, so thank you for that! What would you recommend here?
Thanks for all of your great advice over the years. cheers
Andy
Q: Thoughts on Tucows earnings? In the short term does a pullback present an opportunity to pick up some shares for the long term?
Thanks,
John
Thanks,
John
Q: Hi 5i,
Despite the nice QoQ growth at DOL, the debt is also rising drastically. Is this a concern to you? From what I can tell they are essentially issuing debt to buy back stock - at very elevated prices. This can't go on forever? I have a very healthy gain on the DOL shares that I have left and am considering selling all.
Mike
Despite the nice QoQ growth at DOL, the debt is also rising drastically. Is this a concern to you? From what I can tell they are essentially issuing debt to buy back stock - at very elevated prices. This can't go on forever? I have a very healthy gain on the DOL shares that I have left and am considering selling all.
Mike
Q: Good day, can you please comment on the latest quarter AT just released? The numbers look great to me. Cheers
Q: I have partial positions in efn and gsy. Disregarding everything but growth, would you combine them in gsy? Thanks.
Q: Hi Peter and Team,
Do you have any suggestions for a replacement for MDA?
Thanks,
Jordan
Do you have any suggestions for a replacement for MDA?
Thanks,
Jordan
Q: Hi Team, Sorry about just copying this info, but RBC is doing a better job than I could:
12:23 PM EDT, 05/03/2017 (MT Newswires) -- RBC Capital is initiating coverage on TSO3 with an Outperform, Speculative Risk rating and C$4.25 target. TSO3 has recently commercialized a proprietary and highly differentiated device for the sterilization of medical devices, particularly endoscopes, in healthcare settings, the brokerage reports, adding that the company is therefore uniquely positioned with its marketing partner, Getinge (a world leader in infection control sales). "We expect greater than ~40% returns over the next 12-months."
Price: 3.17, Change: +0.08, Percent Change: +2.6
Would you agree or disagree with RBC on TSO3?
Thanks, Chris
12:23 PM EDT, 05/03/2017 (MT Newswires) -- RBC Capital is initiating coverage on TSO3 with an Outperform, Speculative Risk rating and C$4.25 target. TSO3 has recently commercialized a proprietary and highly differentiated device for the sterilization of medical devices, particularly endoscopes, in healthcare settings, the brokerage reports, adding that the company is therefore uniquely positioned with its marketing partner, Getinge (a world leader in infection control sales). "We expect greater than ~40% returns over the next 12-months."
Price: 3.17, Change: +0.08, Percent Change: +2.6
Would you agree or disagree with RBC on TSO3?
Thanks, Chris
Q: What is your current
View of BUS at the
2.60$ level over the
Next 12 months ?
Thanks. Barry.
View of BUS at the
2.60$ level over the
Next 12 months ?
Thanks. Barry.
Q: Hello! I would appreciate your thoughts on FRII earnings.
Many thanks!
Many thanks!